The two companies want to develop better delivery models for psilocybin treatment. The post Compass Pathways, Journey Clinical to develop...
This story was republished with permission from Crain’s New York. A significant player in the psychedelics industry has received a $5 million infusion...
Companies may have to turn to Big Pharma for help. The post Funding a Major Hurdle for Global Psychedelics Industry, Experts Warn appeared first on Green...
We’re in the midst of festival season in the UK, and with over 50% of festival-goers saying they take drugs it’s important to know how to...
They might not be able to leap tall buildings with a single bound, but leaf-cutting ants are insect superheroes, capable of carrying leaf pieces up to...
The entire psychedelic industry is holding its breath in anticipation of the long-awaited FDA approval of MDMA. It will certainly be a big step for the...
With FDA approval of MDMA therapy estimated to come within the next year, we take a closer look at the road to MDMA legalization. The post...
High costs and regulatory hurdles still need to be overcome by psychedelics industry. The post Denver Psychedelic Conference Focuses on Regulatory Processes,...
All the financial conflict disclosures from Psychedelics Science 2023 speakers, in one handy list. The post Every Disclosed Conflict of Interest at Psychedelic...
The world’s largest psychedelic conference kicked off with workshops and a dive into Burning Man-esque Deep Space. The post Report: Day 1 of MAPS’s...
Blake Mycoskie, founder of Toms Shoes, has pledged to give $100 million to support psychedelic research and access The post Breaking News: Toms Shoes Founder...
New McMaster research has found that a disease-causing fungus — collected from one of the most remote regions in the world — is resistant to a...
A new study shows that psychedelic use was associated with a decreased use of other drugs and substances. The post New Study Shows Psychedelics Associated...
In clinical settings, a racemic mixture of both R and S ketamine is commonly used The post PharmaTher Holdings enters collaboration to commercialize racemic...
Genesys unveiled its Experience Index methodology: the first people-centric approach based on listening and understanding what really motivates stakeholders...
Pharmather has announced a collaboration agreement with Vitruvias Therapeutics for the commercialization of its KETARX (racemic ketamine) products in the...